Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62015TN0355

    Case T-355/15: Action brought on 30 June 2015 — Alpex Pharma v OHIM — Astex Pharmaceuticals (ASTEX)

    IO C 294, 7.9.2015, p. 79–80 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    7.9.2015   

    EN

    Official Journal of the European Union

    C 294/79


    Action brought on 30 June 2015 — Alpex Pharma v OHIM — Astex Pharmaceuticals (ASTEX)

    (Case T-355/15)

    (2015/C 294/95)

    Language in which the application was lodged: English

    Parties

    Applicant: Alpex Pharma SA (Mezzovico-Vira, Switzerland) (represented by: C. Bacchini and M. Mazzitelli, lawyers)

    Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM)

    Other party to the proceedings before the Board of Appeal: Astex Pharmaceuticals, Inc. (Pleasanton, United States)

    Details of the proceedings before OHIM

    Applicant: The other party to the proceedings before the Board of Appeal

    Trade mark at issue: Community word mark ‘ASTEX’ — Application for registration No 1 0 8 05  281

    Procedure before OHIM: Opposition proceedings

    Contested decision: Decision of the Second Board of Appeal of OHIM of 28 April 2015 in Case R 593/2014-2

    Form of order sought

    The applicant claims that the Court should:

    annul the contested decision;

    order OHIM and the other party to the proceedings before the Board of Appeal, should it intervene, to pay the costs.

    Plea in law

    Infringement of Article 8(1)(b) of Regulation No 207/2009.


    Top